We are currently making improvements to the Audible site. In an effort to enhance the accessibility experience for our customers, we have created a page to more easily navigate the new experience, available at the web address www.audible.com/access.
Cured: How the Berlin Patients Defeated HIV and Forever Changed Medical Science | [Nathalia Holt]

Cured: How the Berlin Patients Defeated HIV and Forever Changed Medical Science

Is the end of HIV upon us? Award-winning research scientist and HIV fellow at the Ragon Institute, Nathalia Holt, reveals the science behind the discovery of a functional cure and what it means for the millions affected by HIV and the history of the AIDS pandemic. Two men, known in medical journals as the Berlin Patients, revealed answers to a functional cure for HIV. Their cures came 12 years apart, the first in 1996 and the second in 2008.
Regular Price:$25.20
  • Membership Details:
    • First book free with 30-day trial
    • $14.95/month thereafter for your choice of 1 new book each month
    • Cancel easily anytime
    • Exchange books you don't like
    • All selected books are yours to keep, even if you cancel
  • - or -

Your Likes make Audible better!

'Likes' are shared on Facebook and Audible.com. We use your 'likes' to improve Audible.com for all our listeners.

You can turn off Audible.com sharing from your Account Details page.

OK

Publisher's Summary

Is the end of HIV upon us? Award-winning research scientist and HIV fellow at the Ragon Institute, Nathalia Holt, reveals the science behind the discovery of a functional cure and what it means for the millions affected by HIV and the history of the AIDS pandemic.

Two men, known in medical journals as the Berlin Patients, revealed answers to a functional cure for HIV. Their cures came 12 years apart, the first in 1996 and the second in 2008. Each received his own very different treatment in Berlin, Germany, and each result spurred a new field of investigation, fueling innovative lines of research and sparking hope for the 34 million people currently infected with HIV. For the first time, Nathalia Holt, who has participated in some of the most fruitful research in the field, tells the story of how we came to arrive at this astounding and controversial turning point.

Holt explores the two men’s stories on a personal level, looking at how their experiences have influenced HIV researchers worldwide - including one very special young family doctor who took the time to look closely at his patients - and how they responded to their medications. Based on extensive interviews with the patients and their doctors as well as her own in-depth research, this audiobook is an unprecedented look at how scientists pursue their inquiries, the human impact their research has, and what is and is not working in the relationship between Big Pharma and medical care.

©2014 Nathalia Holt (P)2014 Gildan Media LLC

What the Critics Say

"In this accessible and fascinating account, Holt, a research scientist trained at MIT and Harvard...brings to light the remarkable early breakthroughs in treating a once fatal condition." (Publishers Weekly)

"A fascinating discourse on how medical science is zeroing in on an HIV vaccine after several anomalous triumphs...An astute AIDS retrospective blended with contemporary updates on aggressive medical strategies." (Kirkus Reviews)

What Members Say

Average Customer Rating

3.0 (1 )
5 star
 (0)
4 star
 (0)
3 star
 (1)
2 star
 (0)
1 star
 (0)
Overall
3.0 (1 )
5 star
 (0)
4 star
 (0)
3 star
 (1)
2 star
 (0)
1 star
 (0)
Story
3.0 (1 )
5 star
 (0)
4 star
 (0)
3 star
 (1)
2 star
 (0)
1 star
 (0)
Performance


There are no listener reviews for this title yet.

    There are no listener reviews for this title yet.

Report Inappropriate Content

If you find this review inappropriate and think it should be removed from our site, let us know. This report will be reviewed by Audible and we will take appropriate action.

Cancel

Thank You

Your report has been received. It will be reviewed by Audible and we will take appropriate action.